Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
158,131,900
-
Share change
-
-1,508,325
-
Total reported value
-
$36,800,088,232
-
Put/Call ratio
-
119%
-
Price per share
-
$232.82
-
Number of holders
-
965
-
Value change
-
-$345,789,739
-
Number of buys
-
369
-
Number of sells
-
498
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q3 2019
As of 30 Sep 2019,
BIOGEN INC. - COM (BIIB) was held by
965 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,131,900 shares.
The largest 10 holders included
BlackRock Inc., PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, STATE STREET CORP, Clearbridge Investments, LLC, RENAISSANCE TECHNOLOGIES LLC, WELLINGTON MANAGEMENT GROUP LLP, AQR CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, and Capital World Investors.
This page lists
969
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.